SevenBridge Financial Group’s Kairos Pharma KAPA Stock Holding History
Bought
Maintained
Sold
Other funds holding KAPA
SevenBridge Financial Group's KAPA Position: Q3 2026 in Review
SevenBridge Financial Group sold out of Kairos Pharma (KAPA) in Q3 2026, closing a stake of 6,327 shares — an estimated $17.1K sold.
SevenBridge Financial Group first reported a position in KAPA in Q1 2025 and held it in 6 quarters. The position peaked at $49.6K in Q2 2025. 6 funds tracked by Wall St. Rank hold KAPA as of Q3 2026.
- SevenBridge Financial Group reported no remaining Kairos Pharma position as of Q3 2026 after selling out during the quarter.
- SevenBridge Financial Group sold 6,327 Kairos Pharma shares in Q3 2026, an estimated $17.1K.
- SevenBridge Financial Group first reported a position in Kairos Pharma in Q1 2025 and held it in 6 quarters.
- SevenBridge Financial Group's Kairos Pharma position peaked at $49.6K in Q2 2025.
- 6 funds tracked by Wall St. Rank held Kairos Pharma as of Q3 2026.
Based on SevenBridge Financial Group's 13F filing for Q3 2026, filed 26 Oct 2026.